Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/18/2009EP2118110A1 Cyclopropyl fused indolobenzazepine hcv inhibitors
11/18/2009EP2118109A1 Compounds for the treatment of hepatitis c
11/18/2009EP2118108A1 Compounds for the treatment of hepatitis c
11/18/2009EP2118107A1 Mercaptopurine derivatives as anticancer agents
11/18/2009EP2118103A2 Azaindole derivatives as cftr modulators
11/18/2009EP2118101A1 Imidazo [1,5-a] pyridine derivatives as inhibitors of glutaminyl cyclase
11/18/2009EP2118100A1 New 3- ([1,2,4] triazolo [4,3-a] pyridin-7-yl)benzamide derivatives
11/18/2009EP2118098A2 Polymorphic forms of a macrocyclic inhibitor of hcv
11/18/2009EP2118094A1 Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure
11/18/2009EP2118093A1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
11/18/2009EP2118089A1 Indol-2-yl-piperazin-1-yl-methanone derivatives
11/18/2009EP2118088A1 Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer
11/18/2009EP2118087A1 Pi 3-kinase inhibitors and methods of their use
11/18/2009EP2118084A1 Salts 668
11/18/2009EP2118079A1 Synthetic macrocyclic compounds for treating cancer
11/18/2009EP2118078A2 New salt
11/18/2009EP2118075A1 Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
11/18/2009EP2118074A1 Compounds for the prevention and treatment of cardiovascular diseases
11/18/2009EP2118073A2 Selective endothelin type-a antagonists
11/18/2009EP2118072A1 3 - cinnolinecarboxamide derivatives and their use for treating cancer
11/18/2009EP2118069A2 Bis-aryl amide derivatives useful for the treatment of cancer
11/18/2009EP2118068A1 Indazoles used to treat estrogen receptor beta mediated disorders
11/18/2009EP2118067A1 Nicotinic acetylcholine receptor modulators
11/18/2009EP2118065A1 Novel substituted 1h-benz ýde¨isoquinoline-1, 3 -diones
11/18/2009EP2118064A2 6-aminoisoquinoline compounds useful as kinase modulators
11/18/2009EP2118060A1 1-benzenesulfonyl-1h-indole derivatives as inhibitors of ccr9 activity
11/18/2009EP2118057A1 (indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity
11/18/2009EP2118051A1 New compounds, methods for their preparation and use thereof
11/18/2009EP2118050A2 Aminoalcohol derivatives and their therapeutic use
11/18/2009EP2117598A2 Formulations of deacetylase inhibitors
11/18/2009EP2117565A2 Use of chitosans for the treatment of nail inflammatory diseases
11/18/2009EP2117563A1 Amidinoanthracycline antibiotics for use in the treatment of viral infections
11/18/2009EP2117562A1 Pharmaceutical compositions comprising nk1 receptor antagonists and sodium channel blockers
11/18/2009EP2117561A1 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
11/18/2009EP2117560A1 A composition for selective serotonin reuptake inhibition and process thereof
11/18/2009EP2117559A2 Pharmaceutical composition for the treatment of il-8 mediated diseases
11/18/2009EP2117557A2 Compositions and methods for treatment of colorectal cancer
11/18/2009EP2117555A1 Use of tri-substituted glycerol compounds for the treatment of hematological malignancies
11/18/2009EP2117553A2 Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory track
11/18/2009EP2117552A1 Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases
11/18/2009EP2117551A1 Levosimendan for use in treating chronic valvular disease
11/18/2009EP2117550A1 Use of ranolazine for the treatment of non-coronary microvascular diseases
11/18/2009EP2117549A1 Use of ranolazine for the treatment of coronary microvascular diseases
11/18/2009EP2117548A1 Method of treating multidrug resistant cancers
11/18/2009EP2117547A1 1,2,3,4-tetrahydroisoquinoline derivatives having effects of preventing and treating degenerative and inflammatory diseases
11/18/2009EP2117546A2 Dual bandwidth time difference of arrival (tdoa) system
11/18/2009EP2117545A2 Indenoisoquinolinone analogs and methods of use thereof
11/18/2009EP2117544A2 Biomarker identifying the reactivation of stat3 after src inhibition
11/18/2009EP2117543A2 Potentiation of stem cell homing and treatment of organ dysfunction or organ failure
11/18/2009EP2117541A1 Compounds and compositions as channel activating protease inhibitors
11/18/2009EP2117540A1 New use of glutaminyl cyclase inhibitors
11/18/2009EP2117539A1 A method of administering an antitumor compound
11/18/2009EP2117537A1 Compounds and compositions as channel activating protease inhibitors
11/18/2009EP2117536A2 Cosmetic and pharmaceutical applications of n-acylated amino acids and structurally related compounds
11/18/2009EP2117535A1 Novel pharmaceutical compositions
11/18/2009EP2117534A1 A pharmaceutical composition with atorvastatin active ingredient
11/18/2009EP2117533A1 Pharmaceutical composition on the basis of stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo
11/18/2009EP2117532A1 Chromones as therapeutic agents
11/18/2009EP2117529A2 Methods for treating diseases of altered ige regulation
11/18/2009EP2117527A1 Methods for the treatment of senile dementia of the alzheimer's type
11/18/2009EP2117526A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/18/2009EP2117525A1 Use of 1-phenyl-3-dimethylamino-propane compounds for the therapy of neuropathy pain
11/18/2009EP2117524A1 Use of catecholamines and related compounds as anti-angiogenic agents
11/18/2009EP2117523A1 Inhibitors of akt activity
11/18/2009EP2117521A2 Transdermal delivery systems comprising bupivacaine
11/18/2009EP2117520A1 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
11/18/2009EP2117511A2 Pharmaceutical formulation comprising neurokinin antagonist
11/18/2009EP2117509A1 Use of ranolazine for the treatment of cardiovascular diseases
11/18/2009EP2117508A1 Intravenous solutions comprising ranolazine
11/18/2009EP2117500A1 Dermal film-forming liquid formulations for drug release to skin
11/18/2009EP2117353A1 Process for the manufacture of a powder containing carotenoids
11/18/2009EP2117315A1 Adamantanamines and neramexane salts of thiomolybdic and thiotungstic acids
11/18/2009EP2117313A1 Pharmaceuticals, compositions and methods of making and using the same
11/18/2009EP2117311A1 Therapeutic agents
11/18/2009EP2117309A1 Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
11/18/2009EP2117304A2 Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathy
11/18/2009EP2117302A1 Drug substance preparations, pharmaceutical compositions and dosage forms
11/18/2009EP2117301A1 Use of long-chain alcohol derivatives for the treatment of alopecia areata
11/18/2009EP1996556B1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
11/18/2009EP1971610B1 Salts of clopidogrel with polyanions and their use for manufacturing pharmaceutical formulations
11/18/2009EP1963278B1 Substituted imidazoline derivatives
11/18/2009EP1928842B1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
11/18/2009EP1910359B1 PYRIDO [2 , 3-D]PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS
11/18/2009EP1910340B1 Indazolecarboxamide derivatives as 5ht4 receptor agonists
11/18/2009EP1893609B1 N-(pyridin-2-yl)-sulfonamide derivatives
11/18/2009EP1888538B1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/18/2009EP1873148B1 Pharmaceutical compositions containing crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid
11/18/2009EP1858836B1 Analogues of the azinomycins as anti-tumour agents and as prodrugs
11/18/2009EP1841758B1 Substituted triazole derivatives as oxytocin antagonists
11/18/2009EP1817033B1 Treatment of inflammatory bowel disease
11/18/2009EP1789402B1 2-{-3-2-(phenyl)-oxazol-4-ylmethoxymethyl!-cyclohexylmethoxy };-propionic acid derivatives used as ppar ligandes (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes
11/18/2009EP1768958B1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
11/18/2009EP1765779B1 New substituted piperidines as modulators of dopamine neurotransmission
11/18/2009EP1744736B1 Method of treating dry eye disorders and uveitis
11/18/2009EP1660449B1 Aminopropanol derivatives
11/18/2009EP1615893B1 2-azabicyclo¬3.3.1 nonane derivatives as opioid receptor antagonists
11/18/2009EP1597229B1 Pyrrolidine derivatives as oxytocin antagonists
11/18/2009EP1587474B1 Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses
11/18/2009EP1545453B1 Rifalazil for treating infections of clostridium difficile
11/18/2009EP1529049B1 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
1 ... 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 ... 7860